Teaching Hospital Královské Vinohrady (FNKV)   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Prague Czech Republic (1902)

Organization Overview

First Clinical Trial
2011
NCT01310101
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Faculty Hospital Kralovske Vinohrady | University Hospital Kralovske Vinohrady | University Hospital Královské Vinohrady | University Hospital Vinohrady | Vascular surgery, University hospital Královské Vinohrady, Prague

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction (Phase 4)

Inflammatory Bowel Diseases (Phase 4)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Myocardial Infarction (Phase 4)

Shock (Phase 4)

Shock, Cardiogenic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 22